On Thursday, July 13, the House Labor, Health and Human Services, Education, and Related Agencies Subcommittee of the House Appropriations Committee passed the FY18 National Institutes of Health (NIH) appropriations bill. It now heads to the full committee for consideration.
The bill provides $34.6754 billion in base funding for the NIH and includes the full $496 million designated for FY18 in the NIH Innovation Account established in the 21st Century Cures Act, for $35.1714 billion in total FY18 funding. This marks a $1.1 billion increase from last year; the final FY17 omnibus provided $33.732 billion in base funding and $34.084 billion including money appropriated for 21st Century Cures. The bill rejects the President’s proposal with regards to facilities and administration expenses. The bill also specifies that, “None of the funds made available by this Act may be used to conduct or support research using human fetal tissue if such tissue is obtained pursuant to an induced abortion.” Critical research endeavors were also provided increases:
• $1.8 billion, a $400 million increase, for Alzheimer’s disease research
• $336 million, a $76 million increase, for the Brain Research through Application of Innovative Neurotechnologies (BRAIN) initiative
• $400 million, a $80 million increase, for the All of Us research initiative (formerly called the Precision Medicine Initiative)
• $300 million for the Cancer Moonshot
• $10 million, an $8 million increase, for regenerative medicine research
• $12.6 million for the Gabriella Miller “Kids First” pediatric cancer research initiative.